Dermata Therapeutics, Inc.

DRMAW

—

Advanced chart & tools →

Dermata Therapeutics, Inc.DRMAW

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-8.16

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

—

Net income

$-7.56M

Net margin

—

Gross margin

—

Dividends & financials

Dermata Therapeutics, Inc. (DRMAW) reported revenue of — and net income of $-7.56M, or $-8.16 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.